About this trial
1. Creating a population-based registry system Amyloidosis prospective epidemiological survey
* risk factors * diagnosis * prognosis * treatment * monitoring * survival 2. Describe the occurrence of amyloidosis in the population of HIBA, Hospital Italiano de Buenos Aires. 3. Describe the characteristics of clinical presentation, evolution and predisposing factors of amyloidosis.
Eligibility criteria
Qualifiers
Confirmed amyloidosis: Proof of deposit of amyloid pathology by tissue biopsy in abdominal fat, bone marrow, rectum or organ involved (eg, kidney, liver, sural nerve)
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Locations
1Map coordinates are unavailable for these locations. Locations are shown below instead.
Sponsors and collaborators
Hospital Italiano de Buenos Aires
Lead sponsor
Instituto Cardiovascular de Buenos Aires
Collaborator
Austral University, Argentina
Collaborator
Hospital de Alta Complejidad en Red
Collaborator
Hospital de Clinicas José de San Martín
Collaborator
HOSPITAL BRITANICO DE BUENOS AIRES
Collaborator
Hospital Privado de Rosario
Collaborator
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Collaborator
La Fundacion Favaloro para la Investigacion y la Docencia Medica
Collaborator
Sanatorio Anchorena
Collaborator
Centro Médico Uruguayo, Uruguay
Collaborator
Clínica Foianini, Bolivia
Collaborator